Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation Injuries 1Mucositis 1Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 5Paclitaxel 4Carboplatin 4Pemetrexed 3Docetaxel 3Cisplatin 3Taxes 2Gemcitabine 2Bevacizumab 2satraplatin 1pegfilgrastim 1Watchful Waiting 1Vinorelbine 1Thalidomide 1Sorafenib 1Selenomethionine 1Radiotherapy, Conformal 1Radiation 1Pharmacogenomic Testing 1Neoadjuvant Therapy 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Chemotherapy, Adjuvant 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenocarcinoma, Bronchiolo-Alveolar × Selenomethionine × Clear all
NCT00526890 2017-11-28

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Roswell Park Cancer Institute

Phase 2 Terminated
16 enrolled 11 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡